It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

Pfizer

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Pfizer says pandemic could extend through 2023, studies three-dose vaccine course for children

World / Science & Health Dec 18, 2021

Pfizer says pandemic could extend through 2023, studies three-dose vaccine course for children

Pfizer executives said the company believed that by 2024, the disease should be endemic around the globe, meaning it would no longer be a pandemic.

Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows

Business Dec 17, 2021

Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows

by James Paton

Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.

Pfizer says COVID-19 pill near 90% protective against hospitalization and death

World Dec 15, 2021

Pfizer says COVID-19 pill near 90% protective against hospitalization and death

Recent lab data suggests the drug retains its effectiveness against the fast spreading omicron variant of the coronavirus.

Billionaire’s bet on Pfizer vaccine for China fails to pay off

Business Dec 13, 2021

Billionaire’s bet on Pfizer vaccine for China fails to pay off

Xi Jinping’s administration has backed a nationalist agenda on all fronts, including in the fight against the virus.

Japan in talks with Pfizer about expedited booster shot delivery

National Dec 9, 2021

Japan in talks with Pfizer about expedited booster shot delivery

Japan is due to receive 120 million doses in 2022 from Pfizer, which said Wednesday a third shot of its vaccine appears to offer sufficient protection against the omicron variant.

Pfizer shot provides partial omicron shield, study finds

World Dec 8, 2021

Pfizer shot provides partial omicron shield, study finds

by Antony Sguazzin and Jason Gale

Researchers in South Africa found omicron reduces virus-blocking antibodies by 40-fold in people who have received two doses of the shot.

Japan to make some exceptions to eight-month guideline for COVID-19 booster shots

National Nov 27, 2021

Japan to make some exceptions to eight-month guideline for COVID-19 booster shots

Elderly people in care homes and patients at hospitals hit by cluster infections could receive booster shots six months after their second doses.

Did AstraZeneca keep Britain safer from COVID-19 than Europe?

Commentary / World Nov 26, 2021

Did AstraZeneca keep Britain safer from COVID-19 than Europe?

by Therese Raphael

It's suggested that Britain’s home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?

Japan looks to administer COVID-19 vaccines to children age 5-11 in February

National / Science & Health Nov 18, 2021

Japan looks to administer COVID-19 vaccines to children age 5-11 in February

Some health experts have expressed concern, however, amid uncertainty over the efficacy and safety of the vaccine in children aged under 12.

Pfizer to allow generic versions of its COVID-19 pill in 95 countries

World / Science & Health Nov 16, 2021

Pfizer to allow generic versions of its COVID-19 pill in 95 countries

by Emma Farge and Michael Erman

A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.

Japan to allow COVID-19 booster shots six months after second dose

National / Science & Health Nov 15, 2021

Japan to allow COVID-19 booster shots six months after second dose

Health ministry has set an eight-month interval between second and third shots, but local governments will be able to shorten the period by two months if deemed necessary.

Takeda applies for approval of Moderna's booster shots in Japan

National Nov 12, 2021

Takeda applies for approval of Moderna's booster shots in Japan

A government subcommittee of health experts will discuss the use of the vaccine as a booster shot in late December at the earliest.

« 1 2 3 4 … 13 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times